vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.

Sprout Social, Inc. is the larger business by last-quarter revenue ($120.9M vs $62.1M, roughly 1.9× Cytek Biosciences, Inc.). On growth, Sprout Social, Inc. posted the faster year-over-year revenue change (12.9% vs 8.1%). Sprout Social, Inc. produced more free cash flow last quarter ($9.9M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 11.8%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.

CTKB vs SPT — Head-to-Head

Bigger by revenue
SPT
SPT
1.9× larger
SPT
$120.9M
$62.1M
CTKB
Growing faster (revenue YoY)
SPT
SPT
+4.8% gap
SPT
12.9%
8.1%
CTKB
More free cash flow
SPT
SPT
$11.7M more FCF
SPT
$9.9M
$-1.8M
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
11.8%
SPT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
SPT
SPT
Revenue
$62.1M
$120.9M
Net Profit
$-44.1M
Gross Margin
52.9%
77.6%
Operating Margin
-9.0%
-9.0%
Net Margin
-70.9%
Revenue YoY
8.1%
12.9%
Net Profit YoY
-557.1%
EPS (diluted)
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
SPT
SPT
Q4 25
$62.1M
$120.9M
Q3 25
$52.3M
$115.6M
Q2 25
$45.6M
$111.8M
Q1 25
$41.5M
$109.3M
Q4 24
$57.5M
$107.1M
Q3 24
$51.5M
$102.6M
Q2 24
$46.6M
$99.4M
Q1 24
$44.9M
$96.8M
Net Profit
CTKB
CTKB
SPT
SPT
Q4 25
$-44.1M
Q3 25
$-5.5M
$-9.4M
Q2 25
$-5.6M
$-12.0M
Q1 25
$-11.4M
$-11.2M
Q4 24
$9.6M
Q3 24
$941.0K
$-17.1M
Q2 24
$-10.4M
$-16.9M
Q1 24
$-6.2M
$-13.6M
Gross Margin
CTKB
CTKB
SPT
SPT
Q4 25
52.9%
77.6%
Q3 25
52.7%
77.7%
Q2 25
52.3%
77.7%
Q1 25
48.6%
77.3%
Q4 24
58.5%
78.1%
Q3 24
56.3%
77.4%
Q2 24
54.6%
77.5%
Q1 24
51.3%
76.8%
Operating Margin
CTKB
CTKB
SPT
SPT
Q4 25
-9.0%
-9.0%
Q3 25
-17.6%
-7.9%
Q2 25
-23.3%
-11.0%
Q1 25
-36.1%
-10.2%
Q4 24
5.2%
-12.8%
Q3 24
-8.2%
-16.4%
Q2 24
-18.3%
-16.6%
Q1 24
-23.9%
-13.7%
Net Margin
CTKB
CTKB
SPT
SPT
Q4 25
-70.9%
Q3 25
-10.5%
-8.1%
Q2 25
-12.2%
-10.7%
Q1 25
-27.5%
-10.3%
Q4 24
16.8%
Q3 24
1.8%
-16.6%
Q2 24
-22.4%
-17.0%
Q1 24
-13.8%
-14.0%
EPS (diluted)
CTKB
CTKB
SPT
SPT
Q4 25
$-0.18
Q3 25
$-0.16
Q2 25
$-0.21
Q1 25
$-0.19
Q4 24
$-0.25
Q3 24
$-0.30
Q2 24
$-0.30
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
SPT
SPT
Cash + ST InvestmentsLiquidity on hand
$90.9M
$95.3M
Total DebtLower is stronger
$40.0M
Stockholders' EquityBook value
$341.7M
$203.4M
Total Assets
$461.5M
$523.1M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
SPT
SPT
Q4 25
$90.9M
$95.3M
Q3 25
$93.3M
$90.6M
Q2 25
$75.5M
$101.5M
Q1 25
$95.3M
$100.9M
Q4 24
$98.7M
$86.4M
Q3 24
$162.3M
$82.9M
Q2 24
$177.9M
$80.9M
Q1 24
$168.8M
$69.2M
Total Debt
CTKB
CTKB
SPT
SPT
Q4 25
$40.0M
Q3 25
Q2 25
Q1 25
Q4 24
$25.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CTKB
CTKB
SPT
SPT
Q4 25
$341.7M
$203.4M
Q3 25
$378.6M
$194.1M
Q2 25
$377.6M
$184.6M
Q1 25
$379.6M
$175.3M
Q4 24
$395.7M
$166.6M
Q3 24
$385.5M
$158.1M
Q2 24
$389.1M
$152.1M
Q1 24
$392.6M
$147.3M
Total Assets
CTKB
CTKB
SPT
SPT
Q4 25
$461.5M
$523.1M
Q3 25
$494.9M
$481.4M
Q2 25
$493.3M
$422.9M
Q1 25
$482.6M
$424.7M
Q4 24
$499.5M
$428.3M
Q3 24
$491.2M
$388.8M
Q2 24
$483.7M
$393.6M
Q1 24
$492.1M
$389.9M
Debt / Equity
CTKB
CTKB
SPT
SPT
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
SPT
SPT
Operating Cash FlowLast quarter
$-771.0K
$10.9M
Free Cash FlowOCF − Capex
$-1.8M
$9.9M
FCF MarginFCF / Revenue
-2.9%
8.2%
Capex IntensityCapex / Revenue
1.6%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$39.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
SPT
SPT
Q4 25
$-771.0K
$10.9M
Q3 25
$-3.9M
$9.3M
Q2 25
$108.0K
$5.1M
Q1 25
$-125.0K
$18.1M
Q4 24
$2.0M
$4.1M
Q3 24
$13.2M
$9.0M
Q2 24
$6.2M
$2.1M
Q1 24
$4.0M
$11.2M
Free Cash Flow
CTKB
CTKB
SPT
SPT
Q4 25
$-1.8M
$9.9M
Q3 25
$-4.6M
$8.5M
Q2 25
$-1.5M
$4.2M
Q1 25
$-974.0K
$16.7M
Q4 24
$1.1M
$3.3M
Q3 24
$12.2M
$8.5M
Q2 24
$5.2M
$1.6M
Q1 24
$3.4M
$10.1M
FCF Margin
CTKB
CTKB
SPT
SPT
Q4 25
-2.9%
8.2%
Q3 25
-8.7%
7.4%
Q2 25
-3.2%
3.7%
Q1 25
-2.3%
15.3%
Q4 24
1.9%
3.0%
Q3 24
23.7%
8.3%
Q2 24
11.0%
1.6%
Q1 24
7.6%
10.4%
Capex Intensity
CTKB
CTKB
SPT
SPT
Q4 25
1.6%
0.9%
Q3 25
1.3%
0.7%
Q2 25
3.5%
0.8%
Q1 25
2.0%
1.2%
Q4 24
1.6%
0.8%
Q3 24
2.0%
0.5%
Q2 24
2.3%
0.5%
Q1 24
1.3%
1.1%
Cash Conversion
CTKB
CTKB
SPT
SPT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

SPT
SPT

Segment breakdown not available.

Related Comparisons